Systematic Review
Answers are grounded in this paper and cite their sources.
Supports beta trace protein for kidney and CV risk stratification in diabetes; extends metabolic syndrome associations in guidelines.
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.
No takes yet. Share an insight, caveat, or question.
A 2013 study conducted a systematic review in Type 2 diabetes and kidney disease. Beta trace protein (BTP) levels vs. Standard biomarkers or lower BTP levels was evaluated on Association with kidney disease and metabolic syndrome. Beta trace protein is a promising biomarker of kidney dysfunction in diabetes and is associated with the presence of metabolic syndrome and greater cardiovascular risk.
Synapse has enriched 10 related papers. Consider them for comparative context: